ESR1 and cancer: The relative rarity of benign and malignant tumors arising from RO as contrast to other sites in the female genital tract (FGT) has been attributed to reduced levels of estrogen receptor and progesterone receptor in the rete leading to lesser degree of receptiveness to hormone stimulation in this structure and consequently low proliferation rate in the RO.9